NO146497C - Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner - Google Patents

Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner

Info

Publication number
NO146497C
NO146497C NO753984A NO753984A NO146497C NO 146497 C NO146497 C NO 146497C NO 753984 A NO753984 A NO 753984A NO 753984 A NO753984 A NO 753984A NO 146497 C NO146497 C NO 146497C
Authority
NO
Norway
Prior art keywords
oxazolines
anilino
preparation
therapeutically active
new therapeutically
Prior art date
Application number
NO753984A
Other languages
English (en)
Norwegian (no)
Other versions
NO146497B (no
NO753984L (de
Inventor
Bernard R Neustadt
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of NO753984L publication Critical patent/NO753984L/no
Publication of NO146497B publication Critical patent/NO146497B/no
Publication of NO146497C publication Critical patent/NO146497C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO753984A 1974-12-02 1975-11-26 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner NO146497C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52860374A 1974-12-02 1974-12-02

Publications (3)

Publication Number Publication Date
NO753984L NO753984L (de) 1976-06-03
NO146497B NO146497B (no) 1982-07-05
NO146497C true NO146497C (no) 1982-10-13

Family

ID=24106378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO753984A NO146497C (no) 1974-12-02 1975-11-26 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner

Country Status (26)

Country Link
JP (1) JPS5182239A (de)
AR (2) AR219478A1 (de)
AT (1) AT357557B (de)
AU (1) AU501512B2 (de)
BE (1) BE835899A (de)
CA (1) CA1063112A (de)
CH (1) CH623044A5 (de)
CS (1) CS188259B2 (de)
DD (1) DD124730A5 (de)
DE (1) DE2552933A1 (de)
DK (1) DK535275A (de)
FI (1) FI753332A (de)
FR (1) FR2346000A1 (de)
GB (1) GB1507340A (de)
HU (1) HU175541B (de)
IE (1) IE42759B1 (de)
IL (1) IL48557A (de)
IT (1) IT1051024B (de)
LU (1) LU73888A1 (de)
NL (1) NL7513804A (de)
NO (1) NO146497C (de)
PH (1) PH14474A (de)
PL (2) PL99122B1 (de)
SE (2) SE7513331L (de)
SU (2) SU655311A3 (de)
ZA (1) ZA757457B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52111541A (en) * 1976-02-19 1977-09-19 Scherico Ltd Substituted ureido compound and medical composition containing it as active ingredient
US4107303A (en) 1976-06-24 1978-08-15 E. I. Du Pont De Nemours And Company Antihypertensive hexafluorohydroxyisopropyl benzazepines and benzazocines
DE2839462A1 (de) * 1978-09-11 1980-03-27 Basf Ag Aroylharnstoffe
US6316503B1 (en) 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
EP1476425A4 (de) 2002-01-30 2010-05-05 Amgen Inc Heterocyclische arylsulfonamidobenzyl verbindungen
AU2003210811B2 (en) 2002-01-30 2008-08-14 Amgen Inc. Arylsulfonamidobenzylic compounds
US20030199578A1 (en) * 2002-04-19 2003-10-23 Turner Sean C. Naphthalene amides as potassium channel openers
BR112017008178A2 (pt) 2014-10-24 2017-12-19 Ono Pharmaceutical Co ativador do canal de kcnq2-5
JP6197971B1 (ja) * 2016-04-22 2017-09-20 小野薬品工業株式会社 Kcnq2〜5チャネル関連疾患の予防および/または治療剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453284A (en) * 1966-01-19 1969-07-01 Du Pont Certain 2-(substituted-anilino)-2-oxazolines
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
FR1543535A (fr) * 1966-09-27 1968-10-25 Bayer Ag Procédé de fabrication de 2-phénylamino-2-oxazolines
FR1543534A (fr) * 1966-09-27 1968-10-25 Bayer Ag Procédé de fabrication de 2-phénylimino-oxazolidines
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen

Also Published As

Publication number Publication date
IL48557A0 (en) 1976-01-30
ZA757457B (en) 1976-11-24
DE2552933A1 (de) 1976-06-10
NL7513804A (nl) 1976-06-04
PH14474A (en) 1981-08-07
BE835899A (fr) 1976-05-25
FR2346000A1 (fr) 1977-10-28
SU685146A3 (ru) 1979-09-05
SU655311A3 (ru) 1979-03-30
IT1051024B (it) 1981-04-21
CA1063112A (en) 1979-09-25
CH623044A5 (en) 1981-05-15
PL99122B1 (pl) 1978-06-30
AR218436A1 (es) 1980-06-13
FI753332A (de) 1976-06-03
LU73888A1 (de) 1976-09-06
SE8004364L (sv) 1980-06-11
NO146497B (no) 1982-07-05
ATA898575A (de) 1979-12-15
IE42759B1 (en) 1980-10-08
AR219478A1 (es) 1980-08-29
AU501512B2 (en) 1979-06-21
FR2346000B1 (de) 1978-11-17
PL102327B1 (pl) 1979-03-31
NO753984L (de) 1976-06-03
IE42759L (en) 1976-06-02
HU175541B (hu) 1980-08-28
AT357557B (de) 1980-07-25
JPS5182239A (de) 1976-07-19
GB1507340A (en) 1978-04-12
CS188259B2 (en) 1979-02-28
SE7513331L (sv) 1976-06-03
DD124730A5 (de) 1977-03-09
AU8698975A (en) 1977-06-02
IL48557A (en) 1979-05-31
DK535275A (da) 1976-06-03

Similar Documents

Publication Publication Date Title
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO142813C (no) Analogifremgangsmaate ved fremstilling av det anthelminitisk virksomme, nye metyl-5-propyltio-2-benzimidazolkarbamat
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO148848C (no) Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner
NO145379C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider.
NO144455C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater.
NO144740C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme, substituerte n-(1-benzyl-pyrrolidinyl-2-alkyl)-benzamider
NO150884C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO144743C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye penicillinderivater
NO143846C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater
NO142865C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler
NO143223C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner
NO145618C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive spiro-(1,3-dioxolan-4,3`-kinuclidin-forbindelser
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO146497C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner
NO143026C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme halogenderivater
NO147150C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner.
NO142625C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO144039C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme benzofuranderivater
NO146357C (no) Fremgangsmaate ved fremstilling av nye prostaglandiner